title: A matrix metalloprotease-PAR1 system regulates vascular integrity, systemic inflammation and death in sepsis.
abstract: Sepsis is a deadly disease characterized by the inability to regulate the inflammatory-coagulation response in which the endothelium plays a key role. The cause of this perturbation remains poorly understood and has hampered the development of effective therapeutics. Matrix metalloproteases (MMPs) are involved in the host response to pathogens, but can also cause uncontrolled tissue damage and contribute to mortality. We found that human sepsis patients had markedly elevated plasma proMMP-1 and active MMP-1 levels, which correlated with death at 7 and 28 days after diagnosis. Likewise, septic mice had increased plasma levels of the MMP-1 ortholog, MMP-1a. We identified mouse MMP-1a as an agonist of protease-activated receptor-1 (PAR1) on endothelial cells. MMP-1a was released from endothelial cells in septic mice. Blockade of MMP-1 activity suppressed endothelial barrier disruption, disseminated intravascular coagulation (DIC), lung vascular permeability as well as the cytokine storm and improved survival, which was lost in PAR1-deficient mice. Infusion of human MMP-1 increased lung vascular permeability in normal wild-type mice but not in PAR1-deficient mice. These findings implicate MMP-1 as an important activator of PAR1 in sepsis and suggest that therapeutics that target MMP1-PAR1 may prove beneficial in the treatment of sepsis.
authors: Hemostasis and Thrombosis Laboratory, Departments of Medicine and Biochemistry, Molecular Oncology Research Institute, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA.
authors: Sarah L
authors: SL
authors: Tressel
authors: Nicole C
authors: NC
authors: Kaneider
authors: Shogo
authors: S
authors: Kasuda
authors: Caitlin
authors: C
authors: Foley
authors: Georgios
authors: G
authors: Koukos
authors: Karyn
authors: K
authors: Austin
authors: Anika
authors: A
authors: Agarwal
authors: Lidija
authors: L
authors: Covic
authors: Steven M
authors: SM
authors: Opal
authors: Athan
authors: A
authors: Kuliopulos
references: Crit Care Med. 2007 May;35(5):1244-50
references: 17414736
references: Br J Pharmacol. 2009 Oct;158(4):1034-47
references: 19466992
references: Cell. 2009 Apr 17;137(2):332-43
references: 19379698
references: J Immunol. 2004 Jun 15;172(12):7791-803
references: 15187163
references: N Engl J Med. 2003 Jan 9;348(2):138-50
references: 12519925
references: Crit Care. 2009;13(5):R158
references: 19799791
references: Clin Microbiol Rev. 2009 Apr;22(2):224-39, Table of Contents
references: 19366913
references: Nat Rev Immunol. 2008 Oct;8(10):776-87
references: 18802444
references: Atherosclerosis. 2003 Aug;169(2):235-43
references: 12921974
references: Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):643-8
references: 11805322
references: J Thromb Haemost. 2004 Dec;2(12):2096-102
references: 15613012
references: Arch Surg. 2010 Jul;145(7):695-700
references: 20644134
references: J Clin Invest. 2009 Oct;119(10):2868-78
references: 19805915
references: J Immunol. 2003 Oct 1;171(7):3775-84
references: 14500678
references: Biochem Biophys Res Commun. 2002 Feb 15;291(1):130-8
references: 11829472
references: Methods Enzymol. 2000;325:264-72
references: 11036609
references: Curr Pharm Des. 2003;9(1):75-82
references: 12570677
references: Circ Res. 1998 Nov 30;83(11):1115-23
references: 9831706
references: N Engl J Med. 2001 Mar 8;344(10):699-709
references: 11236773
references: Crit Care Med. 2003 Apr;31(4):1250-6
references: 12682500
references: Trends Immunol. 2004 Oct;25(10):536-42
references: 15364056
references: J Pharmacol Exp Ther. 1999 Feb;288(2):671-8
references: 9918574
references: J Biol Chem. 2009 Jun 26;284(26):17595-606
references: 19407340
references: Science. 2002 Jun 7;296(5574):1880-2
references: 12052963
references: Science. 2010 Feb 5;327(5966):656-61
references: 20133564
references: Biochemistry. 1999 Apr 6;38(14):4572-85
references: 10194379
references: PLoS One. 2007 Mar 21;2(3):e312
references: 17375198
references: Cancer Res. 2006 Aug 1;66(15):7766-74
references: 16885380
references: Biochem Biophys Res Commun. 1994 Mar 30;199(3):1442-6
references: 8147888
references: Circ Res. 2002 May 31;90(10):1093-9
references: 12039799
references: Circulation. 2006 Mar 7;113(9):1244-54
references: 16505172
references: Chest. 1992 Jun;101(6):1644-55
references: 1303622
references: Hum Pathol. 2006 Apr;37(4):422-30
references: 16564916
references: Proc Natl Acad Sci U S A. 1983 Jun;80(12):3734-7
references: 6407019
references: Crit Care Med. 2009 Jan;37(1):96-104
references: 19050610
references: J Exp Med. 2007 Oct 1;204(10):2439-48
references: 17893198
references: Thromb Haemost. 1996 Dec;76(6):860-6
references: 8972001
references: Cell. 2005 Feb 11;120(3):303-13
references: 15707890
references: Lancet Infect Dis. 2008 Jan;8(1):32-43
references: 18063412
references: Am J Pathol. 2007 May;170(5):1435-44
references: 17456750
references: Nat Med. 2005 Jun;11(6):661-5
references: 15880119
references: Lancet. 2005 Jan 1-7;365(9453):63-78
references: 15639681
references: J Biol Chem. 2001 Mar 30;276(13):10253-62
references: 11113146
references: Biochim Biophys Acta. 2010 Jan;1803(1):39-54
references: 19800373
references: Nat Immunol. 2007 Dec;8(12):1303-12
references: 17965715
references: Crit Care Med. 2008 Jan;36(1):296-327
references: 18158437
references: Nat Med. 2002 Nov;8(11):1257-62
references: 12411953
references: Crit Care Med. 2010 Feb;38(2 Suppl):S26-34
references: 20083910
references: Blood. 2004 Feb 15;103(4):1342-7
references: 14576054
references: Hematol J. 2003;4(5):295-302
references: 14502252
references: J Appl Physiol (1985). 1992 Mar;72(3):865-73
references: 1568982